Conference: October 16-17 | In-Person

In an ever-evolving healthcare landscape, real-world evidence (RWE) has emerged as a pivotal tool for shaping regulatory and reimbursement decisions. Traditionally associated with post-market safety monitoring, RWE now plays a critical role throughout the entire product development lifecycle. It enables real-time data analysis to enhance our understanding of diseases, refine treatment approaches, and substantiate coverage decisions.

DIA’s Real-World Evidence Conference is designed to delve into the latest advancements and innovative applications of RWE. From data standards, new regulatory guidances, and advanced approaches for noninterventional studies to the role of RWD in clinical trial diversity, this conference will provide participants with cutting-edge insights into how RWE is transforming drug development and regulatory practices. By exploring new methodologies, technological advancements, and practical case studies, the event will equip attendees with the knowledge and tools necessary to leverage RWE effectively and drive forward healthcare decision-making. Don’t miss this opportunity to stay ahead in the field and harness RWE’s full potential to impact patient outcomes and policy.

While we develop our 2025 agenda, please take a moment to review the last year final agenda.